Guides for performing tests in specific clinical scenarios.

Retinoic acid precursor shows promise in small, uncontrolled study.

Novel formulation may allow mid-potency steroid to act more like high-potency steroid.

A promising new alternative psoriasis treatment.

Data from 2 phase 3 placebo-controlled trials.

A rare study of a pediatric population.

Most patients benefit from minoxidil treatment.

A meta-analysis of retrospective cohort data.

Over 80% of patients maintained PASI75 at 4 years in this open-label extension study.

Narrowband ultraviolet B is a common treatment for several dermatologic diseases.

The drug fulfils NICE's criteria for life-extending therapy.

ASSURE-CSU data suggest that either version can be used.

First systematic review comparing the 2 most relevant treatment options for scabies.

Data from the 2015 National Health Interview Survey.